Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) (Estriol in MS)
This study is currently recruiting participants.
Study NCT00451204 Information provided by University of California, Los Angeles
First Received: March 22, 2007 Last Updated: May 4, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Sclerosis
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Pathologic Processes
Interventions listed in this trial
Estriol
Placebo
Additional drug interventions recognized in this trial
Estrogens
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of California, Los Angeles
University of California, Los Angeles, Los Angeles, CA
Washington University School of Medicine, Saint Louis, MO
University of Texas Southwestern Medical Center
Ohio State University, Columbus, OH
University of Medicine and Dentistry New Jersey, New Brunswick, NJ
University of Chicago
Western Institute for Biomedical Research, Salt Lake City, UT
Johns Hopkins University
Columbia University
University of Kansas, Kansas City, Kansas
University of Minnesota, Minneapolis, MN
Mayo Clinic, Scottsdale, AZ
University of Colorado, Aurora, CO
University of New Mexico, Albuquerque, NM
University of Pennsylvania, Philadelphia, PA
Dartmouth Medical School, Lebanon, NH
National Multiple Sclerosis Society
National Institutes of Health (NIH)
Adeona Pharmaceuticals, Inc.
Back to top of Main Content
